Register entry

Fournier Laboratories Ireland LTD

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 11.

Dosage formNDCs
capsule3
capsule, delayed release2
capsule, delayed release pellets2
tablet2
tablet, film coated2
RouteNDCs
Labeller name on the listingNDCs
fournier laboratories ireland ltd11
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
-Fenofibratetablet68543-3173DRUG FOR FURTHER PROCESSING
-Fenofibratetablet68543-3189DRUG FOR FURTHER PROCESSING
-Fenofibric Acidcapsule, delayed release68543-3161DRUG FOR FURTHER PROCESSING
-Fenofibric Acidcapsule, delayed release68543-3162DRUG FOR FURTHER PROCESSING
-Glecaprevir and Pibrentasvirtablet, film coated68543-2625DRUG FOR FURTHER PROCESSING
-PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASEcapsule, delayed release pellets68543-0045DRUG FOR FURTHER PROCESSING
-Pancrelipasecapsule68543-0046DRUG FOR FURTHER PROCESSING
-Pancrelipasecapsule68543-0047DRUG FOR FURTHER PROCESSING
-Pancrelipasecapsule68543-2636DRUG FOR FURTHER PROCESSING
-Pancrelipasecapsule, delayed release pellets68543-2637DRUG FOR FURTHER PROCESSING
-Venetoclaxtablet, film coated68543-0576DRUG FOR FURTHER PROCESSING
Compare

Other companies listing pancrelipase

Enquiry

Common questions

Is Fournier Laboratories Ireland LTD FDA approved?
Fournier Laboratories Ireland LTD holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Fournier Laboratories Ireland LTD make?
11 products are listed under Fournier Laboratories Ireland LTD in the openFDA NDC Directory, most often as capsule; capsule, delayed release; capsule, delayed release pellets. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.